Task: Answer the MCQ question.
Query: Which drug has a -1.042\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCCc1cc(-c2[nH]ncc2-c2ccc3c(c2)OCCCO3)c(O)cc1O
b.) CCCNC(=O)c1onc(CSc2nc3ccccc3[nH]2)c1C(=O)NCCC
Answer: b. CCCNC(=O)c1onc(CSc2nc3ccccc3[nH]2)c1C(=O)NCCC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1onc(CSc2nc3ccccc3[nH]2)c1C(=O)NCCC
CCCNC(=O)c1onc(CSc2nc3ccccc3[nH]2)c1C(=O)NCCC
3-(1H-benzimidazol-2-ylsulfanylmethyl)-4-N,5-N-dipropyl-1,2-oxazole-4,5-dicarboxamide